Intracranial Stenting of Severe Symptomatic Intracranial Stenosis: Results of 100 Consecutive Patients

References

1. ↵
   Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995;26:14–20

   Abstract/FREE Full Text
2. ↵
   Wityk RJ, Lehman D, Klag M, et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996;27:1974–80

   Abstract/FREE Full Text
3. ↵
   Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555–63

   Abstract/FREE Full Text
4. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16

   CrossRefPubMedWeb of Science
5. ↵
   Kern R, Steinke W, Daffertshofer M, et al. Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology 2005;65:859–64

   Abstract/FREE Full Text
6. ↵
   Yoon W, Seo JJ, Cho KH, et al. Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology 2005;237:620–26

   PubMedWeb of Science
7. Marks MP, Marcellus ML, Do HM, et al. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol 2005;26:525–30

   Abstract/FREE Full Text
8. Chaturvedi S, St Pierre ME, Bertasio B. Cerebral angioplasty practice at major medical centers in the United States. Neuroradiology 2000;42:218–20

   CrossRefPubMedWeb of Science
9. ↵
   Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006;37:1016–20

   Abstract/FREE Full Text
10. ↵
    Dangas G, Fuster V. Management of restenosis after coronary intervention. Am Heart J 1996;132:428–36

    CrossRefPubMedWeb of Science
11. ↵
    Klues HG, Radke PW, Hoffmann R, et al. [Pathophysiology and therapeutic concepts in coronary restenosis]. Herz 1997;22:322–34

    PubMed
12. ↵
    Gomez CR, Misra VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31:95–99

    Abstract/FREE Full Text
13. Levy EI, Horowitz MB, Koebbe CJ, et al. Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 2001;48:1215–21; discussion 1221–23

    CrossRefPubMedWeb of Science
14. Lylyk P, Cohen JE, Ceratto R, et al. Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. AJNR Am J Neuroradiol 2002;23:430–36

    Abstract/FREE Full Text
15. ↵
    Levy EI, Hanel RA, Bendok BR, et al. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg 2002;97:1294–301

    CrossRefPubMedWeb of Science
16. ↵
    Gupta R, Schumacher HC, Mangla S, et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003;61:1729–35

    Abstract/FREE Full Text
17. Levy EI, Hanel RA, Boulos AS, et al. Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar artery. J Neurosurg 2003;99:653–60

    CrossRefPubMedWeb of Science
18. ↵
    de Rochemont Rdu M, Turowski B, Buchkremer M, et al. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents–initial experience. Radiology 2004;231:45–49

    PubMedWeb of Science
19. ↵
    Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577–617

    Abstract/FREE Full Text
20. ↵
    Lee DK, Kim JS, Kwon SU, et al. Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke 2005;36:2583–88

    Abstract/FREE Full Text
21. ↵
    Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 1997;28:307–10

    Abstract/FREE Full Text
22. ↵
    Samuels OB, Joseph GJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643–46

    Abstract/FREE Full Text
23. ↵
    Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490–97

    Abstract/FREE Full Text
24. ↵
    SSYLIVA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388–92

    Abstract/FREE Full Text
25. ↵
    Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007;38:1531–37

    Abstract/FREE Full Text
26. ↵
    Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881–87

    Abstract/FREE Full Text
27. ↵
    van Mook WN, Rennenberg RJ, Schurink GW, et al. Cerebral hyperperfusion syndrome. Lancet Neurol 2005;4:877–88

    CrossRefPubMedWeb of Science
28. ↵
    Alexandrov AV, Felberg RA, Demchuk AM, et al. Deterioration following spontaneous improvement: sonographic findings in patients with acutely resolving symptoms of cerebral ischemia. Stroke 2000;31:915–19

    Abstract/FREE Full Text
29. ↵
    Wagner WH, Cossman DV, Farber A, et al. Hyperperfusion syndrome after carotid endarterectomy. Ann Vasc Surg 2005;19:479–86

    CrossRefPubMedWeb of Science
30. ↵
    Jansen O, Schellinger P, Fiebach J, et al. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 1999;353:2036–37

    CrossRefPubMedWeb of Science
31. ↵
    Arab D, Lewis B, Cho L, et al. Antiplatelet therapy in anticoagulated patients requiring coronary intervention. J Invasive Cardiol 2005;17:549–54

    PubMed
32. ↵
    Reynolds MR, Rinaldi MJ, Pinto DS, et al. Current clinical characteristics and economic impact of subacute stent thrombosis. J Invasive Cardiol 2002;14:364–68

    PubMed
33. ↵
    Mori T, Fukuoka M, Kazita K, et al. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998;19:1525–33

    Abstract
34. ↵
    Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003;108:1772–78

    Abstract/FREE Full Text
35. ↵
    Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 2007;49:1272–78

    CrossRefPubMedWeb of Science